A request from the White House for $228 million in new Food and Drug Administration user fees for fiscal 1995 has been turned down by the House Appropriations Committee subcommittee on agriculture, rural development and related agencies.
The subcommittee has agreed total funding for the FDA in that year of $914 million, plus user fees, which include $79 million in prescription drug user fees.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze